Special Collection on Bioterrorism Research
Stay ahead of this fast-moving field of research by accessing our most relevant papers on the topic of bioterrorism. Available for a limited time, access our collection of relevant and recently-published papers from some of our most prominent titles including Applied Biosafety, Biotechnology Law Report, Foodborne Pathogens and Disease, Health Security, and OMICS: A Journal of Integrative Biology. We are pleased to share this research with you through September 30, 2022.
Aims & Scope
OMICS: A Journal of Integrative Biology is the only peer-reviewed journal covering all trans-disciplinary OMICs-related areas, including data standards and sharing; applications for personalized medicine and public health practice; and social, legal, and ethics analysis. The Journal integrates global high-throughput and systems approaches to 21st century science from “cell to society” – seen from a post-genomics perspective.
In addition, OMICS encourages submission of reports on methods and resources underpinning integrative research, including but not limited to bioinformatics, computational biology, and biomedical informatics; data standards, meta-data, data sharing, databases, biobanks and cloud computing; methodological, statistical, and algorithmic developments; capacity building for developing world OMICS; applications of OMICS for personalized medicine (e.g., pharmacogenomics) and public health practice (e.g., vaccinomics); and social, legal and ethics analyses of OMICS technologies and post-genomics life science innovations.
OMICS: A Journal of Integrative Biology coverage includes:
- All Omics Fields including Multi-Omics Science
- Integrative Biology
- Personalized Medicine
- Biomarkers, Drug Discovery and Development
- Microbial Omics
- Diagnostic Medicine
- Ecology and Environmental Omics
- Implementation Science and Omics
- Omics Technology Policy
- Responsible Innovation, OMICS & Society Research
OMICS: A Journal of Integrative Biology is under the editorial leadership of Editor-in-Chief Vural Özdemir, MD, PhD, DABCP, Toronto, Ontario, Canada, and other leading investigators. View the entire editorial board.
Audience: Integrative biology and multi-omics system scientists; Precision medicine (pharmacogenomics, nutrigenomics, vaccinomics, theranostics) scholars; Medical doctors, nurses, health researchers, patients, engineers and policymakers interested in large scale biology and systems sciences; Bioinformaticians and computational biologists; Biotechnology industry; Scholars in societal and ethical aspects of emerging technologies; among others.
- PubMed Central
- Current Contents®/Life Sciences
- Science Citation Index®
- Biotechnology Citation Index®
- Biochemistry & Biophysics Citation Index®
- Biological Abstracts
- BIOSIS Previews
- Journal Citation Reports/Science Edition
- EMBASE/Excerpta Medica
- Chemical Abstracts
- ProQuest databases
- CAB Abstracts
- Global Health